EU re-inspection delay
EU audit (Hungary) expected in May-June 2026; any delay could postpone regulated market revenue.
medium · management_commentaryLincoln Pharmaceuticals Ltd — Q3 FY26
Lincoln Pharma delivered a solid Q3 FY26 with revenue of ₹166.3 Cr (+13.5% YoY) and PAT of ₹28.6 Cr (+37.7% YoY), driven by strong export growth and the new cephalosporin (CIFA)...
bullish
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
High other income dependence
Other income (forex gains, investment returns) is volatile and contributed ~50% of PBT in 9M; sustainability uncertain.
medium · analyst_questionInorganic growth execution risk
Management is holding cash for acquisitions; if no suitable target found, cash drag may persist.
low · management_commentaryGeopolitical risk in Africa
Africa contributes 40% of exports; currency fluctuations and payment delays are inherent risks.
medium · analyst_question